Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

139
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
139
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

55
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
55

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

[Experience in the use of a vasoactive peptide complex for the treatment of gunshot injuries to limb vessels with arteriovenous fistula formation: a clinical observation].

Khirurgiia·2026
Same journal

[Endovascular closure of a large intrahepatic portosystemic shunt in a 3-month-old infant: the first case in Uzbekistan and literature review].

Khirurgiia·2026
Same journal

[Mediastinal germ cell tumor in an adolescent: a case report].

Khirurgiia·2026
Same journal

[Congenital intrathoracic accessory spleen: a case report].

Khirurgiia·2026
Same journal

[Primary pulmonary leiomyoma: minimally invasive resection of a rare benign tumor].

Khirurgiia·2026
Same journal

[Cefoperazone/sulbactam-induced coagulopathy following pancreatic surgery].

Khirurgiia·2026

Related Experiment Video

Updated: Oct 21, 2025

Model of Ischemia and Reperfusion Injury in Rabbits
06:11

Model of Ischemia and Reperfusion Injury in Rabbits

Published on: November 3, 2023

1.5K

[Ischemia-reperfusion syndrome].

M I Neimark1

  • 1Altai State Medical University, Barnaul, Russia.

Khirurgiia
|September 4, 2021
PubMed
Summary

Ischemia-reperfusion syndrome impacts emergency medicine outcomes. Succinic acid preparations show promise for preventing and treating this condition, offering a hopeful clinical direction.

Area of Science:

  • Clinical Medicine
  • Emergency Medicine
  • Pathophysiology

Background:

  • Ischemia-reperfusion syndrome is a critical complication in emergency medical conditions.
  • It significantly influences disease progression, prognosis, and patient outcomes.
  • Understanding its multifaceted nature is crucial for effective management.

Purpose of the Study:

  • To review the etiology, pathogenesis, and clinical features of ischemia-reperfusion syndrome.
  • To explore current prevention and treatment strategies.
  • To identify promising therapeutic avenues.

Main Methods:

  • Comprehensive literature review of experimental and clinical studies.
  • Analysis of research on the pathophysiology of ischemia-reperfusion.
Keywords:
ischemia-reperfusion syndromepeamberinsuccinate solutions

More Related Videos

Induction and Assessment of Ischemia-reperfusion Injury in Langendorff-perfused Rat Hearts
07:58

Induction and Assessment of Ischemia-reperfusion Injury in Langendorff-perfused Rat Hearts

Published on: July 27, 2015

23.5K
Non-thermal Infrared Light Treatment of Ischemia/Reperfusion Injury and Subsequent Analysis of Macrophage Differentiation
05:24

Non-thermal Infrared Light Treatment of Ischemia/Reperfusion Injury and Subsequent Analysis of Macrophage Differentiation

Published on: December 30, 2021

1.5K

Related Experiment Videos

Last Updated: Oct 21, 2025

Model of Ischemia and Reperfusion Injury in Rabbits
06:11

Model of Ischemia and Reperfusion Injury in Rabbits

Published on: November 3, 2023

1.5K
Induction and Assessment of Ischemia-reperfusion Injury in Langendorff-perfused Rat Hearts
07:58

Induction and Assessment of Ischemia-reperfusion Injury in Langendorff-perfused Rat Hearts

Published on: July 27, 2015

23.5K
Non-thermal Infrared Light Treatment of Ischemia/Reperfusion Injury and Subsequent Analysis of Macrophage Differentiation
05:24

Non-thermal Infrared Light Treatment of Ischemia/Reperfusion Injury and Subsequent Analysis of Macrophage Differentiation

Published on: December 30, 2021

1.5K
  • Evaluation of therapeutic interventions.

    • Main Results:

    • The review covers the complex origins and clinical presentations of the syndrome.
    • Most existing research is experimental, highlighting a gap in clinical data.
    • Succinic acid-based preparations are identified as a potential therapeutic breakthrough.

    Conclusions:

    • Ischemia-reperfusion syndrome poses significant clinical challenges.
    • Further clinical research is needed to validate experimental findings.
    • Succinic acid offers a promising, evidence-based approach for clinical application in managing this syndrome.